FI73679C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat och mellanprodukt foer anvaendning vid foerfarandet. - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat och mellanprodukt foer anvaendning vid foerfarandet. Download PDF

Info

Publication number
FI73679C
FI73679C FI832789A FI832789A FI73679C FI 73679 C FI73679 C FI 73679C FI 832789 A FI832789 A FI 832789A FI 832789 A FI832789 A FI 832789A FI 73679 C FI73679 C FI 73679C
Authority
FI
Finland
Prior art keywords
compound
formula
alkyl
compounds
phenyl
Prior art date
Application number
FI832789A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI832789A (fi
FI73679B (fi
FI832789A0 (fi
Inventor
Peter Gull
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI832789A0 publication Critical patent/FI832789A0/fi
Publication of FI832789A publication Critical patent/FI832789A/fi
Application granted granted Critical
Publication of FI73679B publication Critical patent/FI73679B/fi
Publication of FI73679C publication Critical patent/FI73679C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
FI832789A 1982-08-09 1983-08-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat och mellanprodukt foer anvaendning vid foerfarandet. FI73679C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (de) 1982-08-09 1982-08-09 Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
CH477282 1982-08-09

Publications (4)

Publication Number Publication Date
FI832789A0 FI832789A0 (fi) 1983-08-02
FI832789A FI832789A (fi) 1984-02-10
FI73679B FI73679B (fi) 1987-07-31
FI73679C true FI73679C (fi) 1987-11-09

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832789A FI73679C (fi) 1982-08-09 1983-08-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat och mellanprodukt foer anvaendning vid foerfarandet.

Country Status (23)

Country Link
JP (1) JPS5948480A (fr)
AT (1) AT383125B (fr)
AU (1) AU563736B2 (fr)
BE (1) BE897473A (fr)
CA (1) CA1215972A (fr)
CH (1) CH649998A5 (fr)
DE (1) DE3327705A1 (fr)
DK (1) DK361983A (fr)
ES (1) ES524815A0 (fr)
FI (1) FI73679C (fr)
FR (1) FR2531433B1 (fr)
GB (1) GB2125041B (fr)
GR (1) GR78923B (fr)
HU (1) HU187600B (fr)
IL (1) IL69450A (fr)
IT (1) IT1168961B (fr)
MY (1) MY8700166A (fr)
NL (1) NL8302776A (fr)
NZ (1) NZ205181A (fr)
PH (1) PH20385A (fr)
PT (1) PT77168B (fr)
SE (1) SE8304315L (fr)
ZA (1) ZA835850B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
ES8502992A1 (es) 1985-02-01
IT1168961B (it) 1987-05-20
DE3327705A1 (de) 1984-02-09
FR2531433B1 (fr) 1985-10-18
AU1767283A (en) 1984-02-16
SE8304315D0 (sv) 1983-08-08
DK361983D0 (da) 1983-08-08
HU187600B (en) 1986-01-28
BE897473A (fr) 1984-02-06
IL69450A (en) 1986-10-31
IL69450A0 (en) 1983-11-30
PT77168A (en) 1983-09-01
PT77168B (en) 1986-03-27
CH649998A5 (de) 1985-06-28
MY8700166A (en) 1987-12-31
GB8321222D0 (en) 1983-09-07
NZ205181A (en) 1986-07-11
ES524815A0 (es) 1985-02-01
AT383125B (de) 1987-05-25
AU563736B2 (en) 1987-07-23
GR78923B (fr) 1984-10-02
ATA286383A (de) 1986-10-15
SE8304315L (sv) 1984-02-10
FR2531433A1 (fr) 1984-02-10
FI832789A (fi) 1984-02-10
IT8322490A0 (it) 1983-08-09
CA1215972A (fr) 1986-12-30
PH20385A (en) 1986-12-08
GB2125041B (en) 1986-04-23
NL8302776A (nl) 1984-03-01
DK361983A (da) 1984-02-10
JPS5948480A (ja) 1984-03-19
ZA835850B (en) 1985-03-27
FI73679B (fi) 1987-07-31
GB2125041A (en) 1984-02-29
FI832789A0 (fi) 1983-08-02

Similar Documents

Publication Publication Date Title
EP0760811B1 (fr) Derives d'imidazole modulateurs du recepteur h3 de l'histamine
CA2516660C (fr) Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
JP2022525186A (ja) Ｔｅａｄ転写因子新規小分子阻害剤
EP0482939A1 (fr) Dérive d'isoquinolinone
JP7207634B2 (ja) Ｐ２ｘ３及び／又はｐ２ｘ２／３受容体アンタゴニスト、それを含む医薬組成物及びその使用
PL128296B1 (en) Process for preparing novel 3-/1-imidazolylalkyl/-indoles
EP0204349A2 (fr) Dérivés d'amines hétéroaromatiques, médicaments les contenant et procédé pour leur préparation
FR2852957A1 (fr) Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament
EP1612204A1 (fr) Derive d'hydrazone
WO1995026342A1 (fr) DERIVES DE 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT
JPH0542435B2 (fr)
CA2267154A1 (fr) Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2707645A1 (fr) Dérivés d'imidazo[1,2-a]pirazine-4-one, leur préparation et les médicaments les contenant.
CH666265A5 (fr) Composes polycycliques heterocycliques pharmacologiquement actifs.
EP4382530A1 (fr) Inhibiteur de shp2, composition pharmaceutique le comprenant et son application
FI73679B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat och mellanprodukt foer anvaendning vid foerfarandet.
JPH04217682A (ja) イミダゾ〔１，２−ｃ〕キナゾリン誘導体、これらの製造方法、及びそれらを含む狭心症薬
CA2152401C (fr) Association synergisante ayant un effet antagoniste des recepteurs nk1 et nk2
JPH11508280A (ja) 三環式アミノアルキルカルボキサミド；新規なドーパミンｄ▲下３▼受容体サブタイプに特異的なリガンド
JPH11513376A (ja) 選択的β▲下３▼−アドレナリン作動剤
JP2007297411A (ja) イミダゾ［１，２−ａ］インデノ［１，２−ｅ］ピラジン−２−カルボン酸の誘導体、その製造およびそれを含む薬物
FR2862971A1 (fr) Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
JP2005527518A (ja) 新規なカルコン（ｃｈａｌｃｏｎｅ）誘導体とその使用
WO2005009993A1 (fr) Nouveaux composes
WO2001044207A2 (fr) Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG